Search Count: 189
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.26 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BK0, ADP, MG, SO4 |
 |
Organism: Felis catus
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BK0, ADP, MG, SO4, EDO |
 |
Organism: Felis catus
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BKZ, ADP, MG, SO4, EDO |
 |
Organism: Felis catus
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BKY, ADP, MG, EDO, SO4, CL |
 |
Organism: Felis catus
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BKX, ADP, MG, EDO, SO4, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2025-05-07 Classification: HYDROLASE Ligands: A1BKX, ADP, MG, EDO, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-04-09 Classification: HYDROLASE Ligands: A3P, MG, EDO, CL, PEG |
 |
Solvent Organization In Ultrahigh-Resolution Protein Crystal Structure At Room Temperature
Organism: Crambe hispanica subsp. abyssinica
Method: X-RAY DIFFRACTION Resolution:0.70 Å Release Date: 2024-09-04 Classification: PLANT PROTEIN Ligands: EOH |
 |
Spatial Structure Of Lch-Alpha Peptide From Two-Component Lantibiotic System Lichenicidin Vk21
Organism: Bacillus licheniformis
Method: SOLUTION NMR Release Date: 2023-03-22 Classification: ANTIBIOTIC |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K14 |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K2A |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K20 |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K19 |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K2D |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, F53 |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, K2E |
 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, A61 |
 |
Drug Resistant Hiv-1 Protease (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
 |
Drug Resistant Hiv-1 Protease (L10F, V32I, L33F, K45I, A71V, V82I, I84V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017, SO4 |
 |
Drug Resistant Hiv-1 Protease (L10F, M46I, I47V, I50V, F53L, L63P, I72V, G73S, V82I, I85V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |